CIK 0001528115
- Non-accelerated filer
- Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 275414423
- Phone
- +1 650-822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- 4 Open-market sale President & CEO sold 6,571 shares at $5.87 ($38,564)
- 4 Open-market sale EVP & Chief Business Officer sold 1,645 shares at an average $6.30 ($10,368)
- 4 Open-market sale EVP & Chief Financial Officer sold 1,908 shares at an average $6.31 ($12,035)
- 4 Open-market buy Director bought 2,647,058 shares at $6.80 ($17,999,994)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award EVP & Chief Business Officer acquired 9,375 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award EVP & Chief Scientific Officer acquired 4,688 shares (grant or award)
- 4 Grant or award EVP & Chief Scientific Officer acquired 4,688 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award EVP & Chief Financial Officer acquired 9,375 shares (grant or award)
- 4 Open-market buy Director bought 2,453,988 shares at $3.84 ($9,423,314)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 11 · 206 filings